Hirsch Brian

Director Brian Hirsch buys 80.6K shares of ACVA at $6.21; +421.7% holdings increase amid cluster pattern.

Director Brian Hirsch purchased 80,571 shares at $6.21 on 2025-11-14, increasing his total holdings from 19,107 shares to 99,678 shares—a +421.7% increase. This transaction occurs during a stock decline of -73.1% from the 52-week high of $23.17 and -46.7% over the past 90 days, yet the purchase happens at a price below the current level of $6.24. The buy aligns with a cluster pattern: 2 other insiders have also bought within the past 14 days, suggesting coordinated insider confidence at these depressed levels. Notably, Hirsch's own same-ticker history shows 5 prior sells with mixed timing outcomes (only 2 of 5 well-timed at 90-day mark), so his historical accuracy at this specific ticker is modest. The company posted revenue of $199,561,000.00 and a net loss of $-24,465,000.00 in the latest quarter, with an annual revenue growth of +32.4% but unprofitable full-year results, limiting conviction signals from fundamentals alone.

Director Brian Hirsch sold 146,681 shares of ACVA at $20.69 on 2024-11-12 for $3.0M, reducing holdings 94.1% to 9,239 shares.

Director Brian Hirsch sold 146,681 shares at $20.69 for $3,034,829.89, reducing his stake from 155,920 to 9,239 shares—a 94.1% reduction in holdings. The sale occurred near the company's 52-week high of $21.10, with the stock at $20.37 currently. ACVA is unprofitable (full-year net income of $-16,029,000.00) despite revenue growth of 14.2% annually. Across his cross-ticker track record, Hirsch's prior sells have averaged a 1.0% return at 90 days with a 44.44% well-timed rate, while at ACVA specifically he has completed 4 measurable prior sales with a 50% well-timed rate at the 90-day mark. This filing contains a derivative-conversion transaction; the insider's full position may include derivative securities not yet visible in our database, so the 9,239 shares post-transaction should not be interpreted as a complete position exit.

Director Hirsch Brian sold 61.7K shares of ACVA at $18.63, reducing stake 87.0%; derivative-conversion transaction, position continues.

Director Brian Hirsch sold 61,666 shares at $18.63 on 2024-08-23 in a derivative-conversion transaction, reducing his open-market holdings from 70,905 to 9,239 shares (an 87.0% reduction). The current market price of $18.96 is 1.9% below the 52-week high of $19.32, placing the stock near recent peaks. At ACVA specifically, Hirsch's prior five trades show mixed outcomes: his most recent measurable 90-day result (2024-03-14 sell) was +8.8%, while the 2024-06-10 sell posted -8.4% at 30 days, suggesting inconsistent post-sale price action. The company remains unprofitable on a full-year basis despite 14.2% annual revenue growth, which adds fundamental context to equity sales by insiders. Because this is a derivative-conversion transaction rather than a full-position liquidation, the sale represents a conversion-driven reduction of Table I holdings rather than a discretionary exit signal.